Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
10/2001
10/11/2001WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001WO2001074369A1 Divided dose therapies with vascular damaging activity
10/11/2001WO2001074368A1 Combination therapies with vascular damaging activity
10/11/2001WO2001074341A2 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
10/11/2001CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001CA2402539A1 Combination therapies with vascular damaging activity
10/11/2001CA2402078A1 Divided dose therapies with vascular damaging activity
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140291A1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor
10/10/2001EP1140189A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/10/2001EP1140187A1 Combinations for cardiovascular indications
10/10/2001EP1140145A2 Novel exendin agonist formulations and methods of administration thereof
10/10/2001EP1140124A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine
10/10/2001EP1140115A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
10/10/2001EP1140102A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/04/2001EP1137644A1 Benzofuran derivatives, their preparation and use
10/04/2001EP1137642A1 Bis-sulfonamides
10/03/2001CN1315855A Immediate release tablet
09/2001
09/27/2001WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
09/27/2001US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants
09/26/2001EP1135391A1 Novel triazolo(4,5-d)pyrimidine compounds
09/26/2001EP1135381A1 Eletriptan hydrobromide monohydrate
09/19/2001EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors
09/18/2001US6291458 Morpholinobenzamide salts
09/13/2001WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals
09/13/2001WO2001028992A3 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/12/2001EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
09/12/2001CN1312724A TNF-drvived peptides of use in treating oedema
09/07/2001WO2001064672A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
09/07/2001WO2001064229A1 A medicine for treating obesity and the method of producing thereof
09/06/2001US20010020016 Formulation
09/05/2001EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
09/04/2001US6284272 Pharmaceutical compositions containing an effervescent acid-base couple
08/2001
08/30/2001WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide
08/29/2001EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery
08/29/2001CN1310620A Use of glucose uptake enhancer for reducing apoptosis
08/28/2001US6280777 Soya extract, process for its preparation and pharmaceutical composition
08/22/2001EP1125585A1 Remedies for immunological diseases
08/22/2001EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/16/2001US20010014689 Nervous system disorders
08/15/2001CN1307867A Mizoribine tablet with improved color
08/09/2001WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001057032A1 C10 ester substituted taxanes as antitumor agents
08/09/2001WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents
08/09/2001WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation
08/09/2001WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/09/2001WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
08/09/2001WO2001014376A8 Novel spiro compounds
08/09/2001CA2399123A1 Medicament for treating aseptic inflammations containing anemonin as effective component
08/09/2001CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/09/2001CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001CA2368540A1 C7 carbonate substituted taxanes as antitumor agents
08/09/2001CA2368534A1 C7 heterosubstituted acetate taxanes as antitumor agents
08/09/2001CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001CA2368151A1 C10 carbonate substituted taxanes as antitumor agents
08/08/2001EP1121112A2 Storable active substance concentrate with formoterol
08/08/2001CN1306818A Medicine for treating abacterial inflammation and its extraction method
08/02/2001WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
08/02/2001WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/2001
07/26/2001DE10100779A1 Formulierung Formulation
07/25/2001EP1117652A1 Tan-1057 derivatives
07/19/2001WO2001051078A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
07/19/2001US20010008639 Reducing dosage; analgesics
07/19/2001CA2396157A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
07/17/2001US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
07/12/2001WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
07/10/2001WO2001051056A1 Fulvestrant formulation
07/05/2001WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
07/05/2001US20010006976 Efficent, notoxic process of making new key intermediate quaternary ammonium salts and 2-oxazolylalkyl sulfide derivatives and avoids the reaction of a-haloketones with an azide followed by reducing the resulting a-aminoketone
07/05/2001US20010006686 Extract; antiinflammatory agent for treatment of cyclooxygenase-2 (COX-2) conditions such as arthritis, pain from cancer; selective inhibition of COX-2 over COX-1
07/05/2001CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
06/2001
06/28/2001WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
06/27/2001EP1109537A1 Immediate release tablet
06/26/2001US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract
06/26/2001US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution
06/21/2001WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases
06/21/2001CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases
06/14/2001WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS
06/13/2001EP1105152A1 Tnf-derived peptides for use in treating oedema
06/13/2001EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body
05/2001
05/31/2001WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/29/2001US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring
05/17/2001WO2001034593A1 Compound with growth hormone releasing properties
05/17/2001WO2001034551A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
05/17/2001WO2001034189A2 Vaccines for mycoplasma bovis and methods of use
05/17/2001CA2390613A1 Vaccines for mycoplasma bovis and methods of use
05/16/2001EP1098657A1 Composition for treating obesity and aesthetic treatment method
05/16/2001EP1098639A1 Use of a glucose uptake enhancer for reducing apoptosis
05/15/2001US6231887 Drugs of pyranone derivatives
05/10/2001WO2001032651A1 Quinazoline derivatives as vegf inhibitors
05/09/2001EP1097937A1 N-acyl derivatives of the LL-E33288 antitumor antibiotics
05/03/2001WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32